Carregant...
Toxicity of initial chemotherapy in older patients with lung cancers
OBJECTIVES: Despite the growing number of elderly patients with lung cancers, we lack adequate information about how best to treat them. A phase III trial demonstrated a survival benefit of doublet chemotherapy in elderly patients with lung cancers compared to single agents at the cost of increased...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3601754/ https://ncbi.nlm.nih.gov/pubmed/23525607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jgo.2012.09.003 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|